title: Key structural features of prostaglandin E(2) and prostanoid analogs involved in binding and activation of the human EP(1) prostanoid receptor.
abstract: The structure-activity relationship (SAR) of prostaglandin (PG) E(2) at the human EP(1) prostanoid receptor (designated hEP(1)) was examined via the binding and activation of this receptor by a series of 55 prostanoids and analogs. Using clonal human embryonic kidney 293 cell lines expressing recombinant hEP(1), affinity (K(i)), potency (EC(50)), and efficacy data were obtained using a radioligand competitive binding assay and an aequorin-based calcium functional assay. All compounds behaved as full agonists (90-100% of the response elicited by PGE(2)) in this assay, and the correlation between the K(i) and EC(50) values was highly significant (R(2) = 0.86). The results from the SAR analysis can be summarized as follows: 1) the existence and configuration of hydroxyl groups at the 11 and 15 positions of PGE(2) and prostanoid analog structures play a critical role in agonist activity; 2) the carboxyl group is also important for activity and modification of the carboxylic acid to various esters results in greatly reduced affinity and potency; 3) the activity of structures with moderate or weak potency can be enhanced by modification of the omega-tail; and 4) modifications to the ketone at the 9-position are better tolerated, with 9-deoxy-9-methylene-PGE(2) being the most potent agonist tested in the functional assay. The impact of other modifications on agonist potency is also discussed. The results from this study have identified, for the first time, the key structural features of PGE(2) and related prostanoids and prostanoid analogs necessary for activation of hEP(1).
authors.affiliation: Department of Biochemistry and Molecular Biology, Merck Frosst Center for Therapeutic Research, Pointe Claire-Dorval, Quebec, H9R 4P8 Canada.
authors.forename: M D
authors.initials: MD
authors.lastname: Ungrin
authors.forename: M C
authors.initials: MC
authors.lastname: Carrière
authors.forename: D
authors.initials: D
authors.lastname: Denis
authors.forename: S
authors.initials: S
authors.lastname: Lamontagne
authors.forename: N
authors.initials: N
authors.lastname: Sawyer
authors.forename: R
authors.initials: R
authors.lastname: Stocco
authors.forename: N
authors.initials: N
authors.lastname: Tremblay
authors.forename: K M
authors.initials: KM
authors.lastname: Metters
authors.forename: M
authors.initials: M
authors.lastname: Abramovitz
mesh_terms: D001665:Binding Sites; D002478:Cells, Cultured; D015232:Dinoprostone / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D008968:Molecular Conformation; D011453:Prostaglandins / Q000737:chemistry / Q000378:metabolism*; D011869:Radioligand Assay; D018078:Receptors, Prostaglandin E / Q000378:metabolism*; D058306:Receptors, Prostaglandin E, EP1 Subtype; D013329:Structure-Activity Relationship
chemical_list: C545635:PTGER1 protein, human; D011453:Prostaglandins; D018078:Receptors, Prostaglandin E; D058306:Receptors, Prostaglandin E, EP1 Subtype; D015232:Dinoprostone